je.st
news
Zacks Investment Research Upgrades Immunomedics, Inc. (IMMU) to Buy
2016-04-11 03:27:16| Biotech - Topix.net
The firm currently has a $3.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's price target points to a potential upside of 12.78% from the company's previous close.
Tags: buy
research
investment
upgrades
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||